CLINICAL_TRIALS
research
· 2017-08-30
Clinical Trial Update: Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
Summary
Clinical trial assessing whether CHA2DS2-VASC score and the ratio of contrast volume to creatinine clearance can predict contrast-induced nephropathy in patient…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assiut University | Conditions: Contrast-induced Nephropathy | Status: UNKNOWN